Toronto Dominion Bank increased its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 1.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 461,226 shares of the company's stock after purchasing an additional 6,386 shares during the quarter. Toronto Dominion Bank owned approximately 0.06% of Colgate-Palmolive worth $47,880,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of CL. Acadian Asset Management LLC raised its holdings in Colgate-Palmolive by 108.4% during the 2nd quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company's stock valued at $551,367,000 after acquiring an additional 2,955,442 shares during the period. FMR LLC grew its position in shares of Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company's stock valued at $700,642,000 after purchasing an additional 2,674,807 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Colgate-Palmolive by 40.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company's stock valued at $870,400,000 after purchasing an additional 2,593,313 shares during the period. Barclays PLC lifted its holdings in Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. Finally, State Street Corp boosted its stake in Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after purchasing an additional 1,784,411 shares during the period. Hedge funds and other institutional investors own 80.41% of the company's stock.
Insider Transactions at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.37% of the company's stock.
Colgate-Palmolive Trading Up 0.9 %
Shares of CL traded up $0.82 during trading hours on Thursday, hitting $93.58. The company had a trading volume of 3,519,581 shares, compared to its average volume of 4,378,095. Colgate-Palmolive has a 52-week low of $75.50 and a 52-week high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock's 50 day moving average price is $95.97 and its 200 day moving average price is $98.62. The firm has a market cap of $76.46 billion, a P/E ratio of 26.58, a P/E/G ratio of 3.36 and a beta of 0.43.
Colgate-Palmolive Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. Colgate-Palmolive's dividend payout ratio is currently 57.31%.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the stock. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a report on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 price target on the stock. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and increased their target price for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Monday, November 25th. Stifel Nicolaus downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. Finally, JPMorgan Chase & Co. boosted their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a research report on Friday, October 11th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $105.11.
Get Our Latest Analysis on CL
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.